Exhibit 99.1

 

NEWGENIVF GROUP LIMITED
UNAUDITED CONSOLIDATED BALANCE SHEETS

(Stated in US Dollars)

 

   June 30,   December 31, 
   2026   2025 
ASSETS  (unaudited)   (audited) 
Current assets        
Cash and cash equivalents  $1,023,789   $758,621 
Accounts receivable, net   115,970    166,531 
Inventories   351,366    335,360 
Deposits, prepayments and other receivables, net   4,482,625    503,588 
Deposit for land acquisition   4,714,749    4,614,749 
Deposit with a digital asset trading platform   4,717    34,987 
Deposit with futures broker, net   —    59,369 
Receivable from agents, net   392,876    794,116 
Deferred offering costs   40,754    116,250 
Total current assets   11,126,846    7,383,571 
           
Non-current assets          
Plant and equipment, net   1,733,832    1,789,110 
Right-of-use assets, net   473,732    504,192 
Intangible assets   21,415,893    21,415,069 
Digital asset, at fair value   —    1,630,827 
Investment in equity securities   1,686,667    — 
           
Total non-current assets   25,310,124    25,339,198 
           
TOTAL ASSETS  $36,436,970   $32,722,769 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities          
Accounts payable  $878,108   $779,280 
Accrued liabilities and other payables   500,236    711,892 
Contract liabilities   105,835    111,981 
Due to related parties   64,481    6,421 
Operating lease liabilities, current   263,532    238,105 
Convertible notes   1,104,543    256,056 
Embedded derivative liability   710,536    262,616 
Repurchase Forbearance liability   6,881,250    — 
Total current liabilities   10,508,521    2,366,351 
           
Non-current liabilities          
Operating lease liabilities, non-current   215,087    272,359 
Convertible notes, non-current   --    4,097,366 
           
Total non-current liabilities   215,087    4,369,725 
           
Total liabilities  $10,723,608   $6,736,076 
           
Shareholders’ equity          
Ordinary shares, no par value, unlimited authorized shares and 1,152,607* and 26,736* shares issued and outstanding as of June 30, 2026 and December 31, 2025 respectively   —    — 
Additional paid-in capital   25,786,740    17,881,176 
Retained Earnings / (Accumulated deficit)   857,860    8,893,414 
Accumulated other comprehensive (loss) income   (215,658)   (143,071)
Equity attributable to the shareholders of the Company   26,428,942    26,631,519 
Non-controlling interests   (715,580)   (644,826)
Total shareholders’ equity   25,713,362    25,986,693 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $36,436,970   $32,722,769 

 

*The shares as presented have been adjusted retrospectively for Reverse Share Splits effected in January 2026 of 1 share for every 3 existing shares issued, in March 2026 of 1 share for every 4 existing share issued, in July 2026 of 1 share for every 3 shares issued and in September 2026 of 1 share for every 3 shares issued respectively.

 

2

 

 

NEWGENIVF GROUP LIMITED
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND

COMPREHENSIVE (LOSS) INCOME
(Stated in US Dollars)

Six Months Ended

 

   June 30,
2026
   June 30,
2025
 
Revenues  $1,924,881   $2,019,628 
Cost of revenues   (1,460,393)   (1,705,824)
Gross profit   464,488    313,804 
           
Operating expenses          
Selling and marketing expenses   (416,238)   (307,176)
General and administrative expenses   (3,595,662)   (3,247,004)
           
Total operating expenses   (4,011,900)   (3,554,180)
           
Operating income (loss)   (3,547,412)   (3,240,376)
           
Other income (expenses), net          
Other income (expenses), net   (3,990,911)   4,062,303 
Interest income   64    1,594 
Interest expense   (541,133)   (357,551)
Total other income (expenses), net   (8,079,392)   (3,938,408)
           
Income (loss) before taxes   (8,079,392)   698,032 
Provision for income taxes   ---    --- 
Net income (loss)   (8,079,392)   698,032 
Less: net loss attributable to non-controlling interests   (44,086)   (26,943)
Net income (loss) attributable to the shareholders of the Company  $(8,035,306)   724,975 
           
Other comprehensive (loss) income          
Foreign currency translation adjustment   (99,506)   (66,526)
Total comprehensive income (loss)   (8,178,898)   631,506 
           
Less: total comprehensive loss attributable to non-controlling interests   (70,754)   (54,536)
Total comprehensive income (loss) attributable to the shareholders of the Company  $(8,108,144)   686,042 
           
Earning per share – basic  $(26.64)   1,418.76 
Basic weighted average shares outstanding*   301,584    511 

 

*The shares as presented have been adjusted retrospectively for Reverse Share Splits effected in January 2026 of 1 share for every 3 existing shares issued, in March 2026 of 1 share for every 4 existing share issued, in July 2026 of 1 share for every 3 shares issued and in September 2026 of 1 share for every 3 shares issued respectively.

 

3